|
"pan mr"的相关文件
显示项目 1-25 / 34 (共2页)
1 2 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2024-06-30 |
Increased blood CSF3R+myeloid-derived suppressor cell is a predictor for breast cancer recurrence
|
Li, YL;Chen, CH;Lai, YS;Pan, MR;Hung, WC |
| 國家衛生研究院 |
2024-02-20 |
Chromatin remodeling-related PRDM1 increases stomach cancer proliferation and is counteracted by bromodomain inhibitor
|
Hung, YH;Wang, HC;Pan, MR;Chen, LT |
| 國家衛生研究院 |
2023-11-22 |
The prognosis performance of a neutrophil- and lymphocyte-associated gene mutation score in a head and neck cancer cohort
|
Yeh, TJ;Wang, HC;Cho, SF;Wu, CC;Hsieh, TY;Huang, CT;Wang, MH;Chuang, TM;Gau, YC;Du, JS;Liu, YC;Hsiao, HH;Pan, MR;Chen, LT;Moi, SH |
| 國家衛生研究院 |
2023-05-01 |
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
|
Wang, HC;Moi, SH;Chan, LP;Wu, CC;Du, JS;Liu, PL;Chou, MC;Wu, CW;Huang, CJ;Hsiao, HH;Pan, MR;Chen, LT |
| 國家衛生研究院 |
2023-02-24 |
Deciphering the functions of telomerase reverse transcriptase in head and neck cancer
|
Yeh, TJ;Luo, CW;Du, JS;Huang, CT;Wang, MH;Chuang, TM;Gau, YC;Cho, SF;Liu, YC;Hsiao, HH;Chen, LT;Pan, MR;Wang, HC;Moi, SH |
| 國家衛生研究院 |
2022-12-15 |
Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway
|
Wang, HC;Luo, CW;Chen, TY;Chen, YZ;Fang, SY;Lai, CY;Hung, WC;Wu, CC;Chen, LT;Liu, YC;Pan, MR |
| 國家衛生研究院 |
2022-09-21 |
Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer
|
Wang, HC;Shih, HY;Wu, CC;Chen, LT;Luo, CW;Liu, YC;Du, JS;Huang, MC;Su, YY;Chen, HD;Hsiao, HH;Moi, SH;Pan, MR |
| 國家衛生研究院 |
2021-07-31 |
BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer[Erratum:Radiotherapy and Oncology. 2020 Aug;149:249-258.]
|
Hsu, YC;Luo, CW;Huang, WL;Wu, CC;Chou, CL;Chen, CI;Chang, SJ;Chai, CY;Wang, HC;Chen, TY;Li, CF;Pan, MR |
| 國家衛生研究院 |
2020-11 |
High expression of UBE2B as a poor prognosis factor in patients with rectal cancer following chemoradiotherapy
|
Huang, WL;Luo, CW;Chou, CL;Yang, CC;Chen, TJ;Li, CF;Pan, MR |
| 國家衛生研究院 |
2020-08 |
BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
|
Hsu, YC;Luo, CW;Huang, WL;Wu, CC;Chou, CL;Chen, CI;Chang, SJ;Chai, CY;Wang, HC;Chen, TY;Li, CF;Pan, MR |
| 國家衛生研究院 |
2019-08-21 |
Over-expression of CHD4 Is an independent biomarker of poor prognosis in patients with rectal cancers receiving concurrent chemoradiotherapy
|
Wang, HC;Chou, CL;Yang, CC;Huang, WL;Hsu, YC;Luo, CW;Chen, TJ;Li, CF;Pan, MR |
| 國家衛生研究院 |
2019-07 |
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
|
Hsu, MC;Tsai, YL;Lin, CH;Pan, MR;Shan, YS;Cheng, TY;Cheng, SHC;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2019-06-24 |
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication
|
Hung, YH;Hsu, MC;Chen, LT;Hung, WC;Pan, MR |
| 國家衛生研究院 |
2019-03-21 |
Two birds, one sone: Double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3
|
Hsu, MC;Pan, MR;Hung, WC |
| 國家衛生研究院 |
2019-01-02 |
FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer
|
Pan, MR;Hou, MF;Ou-Yang, F;Wu, CC;Chang, SJ;Hung, WC;Yip, HK;Luo, CW |
| 國家衛生研究院 |
2018-12-20 |
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression
|
Hsu, MC;Pan, MR;Chu, PY;Tsai, YL;Tsai, CH;Shan, YS;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2018-11-13 |
From friend to enemy: Dissecting the functional alteration of immunoregulatory components during pancreatic tumorigenesis
|
Wang, HC;Hung, WC;Chen, LT;Pan, MR |
| 國家衛生研究院 |
2018-09-15 |
Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer
|
Tian, YF;Wang, HC;Luo, CW;Hung, WC;Lin, YH;Chen, TY;Li, CF;Lin, CY;Pan, MR |
| 國家衛生研究院 |
2018-09-06 |
Cell motility facilitated by mono(2-ethylhexyl) phthalate via activation of the AKT-beta-catenin-IL-8 axis in colorectal cancer
|
Luo, CW;Hsiao, IL;Wang, JY;Wu, CC;Hung, WC;Lin, YH;Chen, TY;Hsu, YC;Cheng, TL;Pan, MR |
| 國家衛生研究院 |
2018-02 |
CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells
|
Luo, CW;Wu, CC;Chang, SJ;Chang, TM;Chen, TY;Chai, CY;Chang, CL;Hou, MF;Pan, MR |
| 國家衛生研究院 |
2017-09 |
G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response
|
Luo, CW;Wang, JY;Hung, WC;Peng, G;Tsai, YL;Chang, TM;Chai, CY;Lin, CH;Pan, MR |
| 國家衛生研究院 |
2017-08-24 |
The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer
|
Hou, MF;Luo, CW;Chang, TM;Hung, WC;Chen, TY;Tsai, YL;Chai, CY;Pan, MR |
| 國家衛生研究院 |
2017-07-17 |
Orchestration of H3K27 methylation: Mechanisms and therapeutic implication
|
Pan, MR;Hsu, MC;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2016-11 |
Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer
|
Hung, WC;Pan, MR;Hsu, MC;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2016-09 |
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
|
Pan, MR;Hsu, MC;Luo, CW;Chen, LT;Shan, YS;Hung, WC |
显示项目 1-25 / 34 (共2页)
1 2 > >>
每页显示[10|25|50]项目
|
